naproxen sodium; sumatriptan succinate · Azurity · NDA 021926
Treximet
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 021926 · 001 · RLD | tablet, oral | 500MG;EQ 85MG BASE | open |
| 021926 · 002 · RLD · discontinued | tablet, oral | 60MG;EQ 10MG BASE | open |
Expired or delisted (3)
- US 7332183 · — · 2 Apr 2026
- US 7332183 · product, use U-867 · 2 Oct 2025
- US 7332183 · product, use U-1719 · 2 Oct 2025